Methodology for conduct of epidemiologic surveys and randomized controlled trials of diabetic polyneuropathy

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

This chapter outlines: (1) the reasons why epidemiologic surveys and randomized controlled clinical trials (RCTs) of diabetic polyneuropathy (DPN) are difficult and expensive, and often poorly done, (2) primary and secondary neuropathy end points, (3) single versus composite neuropathic end points, (4) adequate reference values from study of population representative cohorts, and (5) the issue of clinical proficiency.

Original languageEnglish (US)
Pages (from-to)335-338
Number of pages4
JournalHandbook of Clinical Neurology
Volume126
DOIs
StatePublished - 2014

Fingerprint

Diabetic Neuropathies
Reference Values
Randomized Controlled Trials
Population
Surveys and Questionnaires

Keywords

  • Polyneuropathy end points
  • Randomized controlled clinical trials
  • Standard reference values of neurophysiologic tests

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

@article{b74ecf7856ef4453bb5797ba405dc503,
title = "Methodology for conduct of epidemiologic surveys and randomized controlled trials of diabetic polyneuropathy",
abstract = "This chapter outlines: (1) the reasons why epidemiologic surveys and randomized controlled clinical trials (RCTs) of diabetic polyneuropathy (DPN) are difficult and expensive, and often poorly done, (2) primary and secondary neuropathy end points, (3) single versus composite neuropathic end points, (4) adequate reference values from study of population representative cohorts, and (5) the issue of clinical proficiency.",
keywords = "Polyneuropathy end points, Randomized controlled clinical trials, Standard reference values of neurophysiologic tests",
author = "Dyck, {Peter J}",
year = "2014",
doi = "10.1016/B978-0-444-53480-4.00024-2",
language = "English (US)",
volume = "126",
pages = "335--338",
journal = "Handbook of Clinical Neurology",
issn = "0072-9752",
publisher = "Elsevier",

}

TY - JOUR

T1 - Methodology for conduct of epidemiologic surveys and randomized controlled trials of diabetic polyneuropathy

AU - Dyck, Peter J

PY - 2014

Y1 - 2014

N2 - This chapter outlines: (1) the reasons why epidemiologic surveys and randomized controlled clinical trials (RCTs) of diabetic polyneuropathy (DPN) are difficult and expensive, and often poorly done, (2) primary and secondary neuropathy end points, (3) single versus composite neuropathic end points, (4) adequate reference values from study of population representative cohorts, and (5) the issue of clinical proficiency.

AB - This chapter outlines: (1) the reasons why epidemiologic surveys and randomized controlled clinical trials (RCTs) of diabetic polyneuropathy (DPN) are difficult and expensive, and often poorly done, (2) primary and secondary neuropathy end points, (3) single versus composite neuropathic end points, (4) adequate reference values from study of population representative cohorts, and (5) the issue of clinical proficiency.

KW - Polyneuropathy end points

KW - Randomized controlled clinical trials

KW - Standard reference values of neurophysiologic tests

UR - http://www.scopus.com/inward/record.url?scp=84921953762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921953762&partnerID=8YFLogxK

U2 - 10.1016/B978-0-444-53480-4.00024-2

DO - 10.1016/B978-0-444-53480-4.00024-2

M3 - Article

C2 - 25410232

AN - SCOPUS:84921953762

VL - 126

SP - 335

EP - 338

JO - Handbook of Clinical Neurology

JF - Handbook of Clinical Neurology

SN - 0072-9752

ER -